pharmacokinetics

(redirected from Pharmakinetics)
Also found in: Thesaurus, Medical, Encyclopedia.

phar·ma·co·ki·net·ics

 (fär′mə-kō-kə-nĕt′ĭks, -kī-)
n. (used with a sing. verb)
1. The process by which a drug is absorbed, distributed, metabolized, and eliminated by the body.
2. The study of this process.

phar′ma·co·ki·net′ic adj.

pharmacokinetics

(ˌfɑːməkəʊkɪˈnɛtɪks; -kaɪ-)
n
(Pharmacology) the branch of pharmacology concerned with the way drugs are taken into, move around, and are eliminated from, the body
ˌpharmacokiˈnetic adj
ˌpharmacokiˈnetically adv
pharmacokineticist n

phar•ma•co•ki•net•ics

(ˌfɑr mə koʊ kɪˈnɛt ɪks, -kaɪ-)

n.
(used with a pl. v.) the actions of drugs within the body, as their absorption, distribution, metabolism, and elimination.
[1955–60]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.pharmacokinetics - the study of the action of drugs in the body: method and rate of excretion; duration of effect; etc.
materia medica, pharmacological medicine, pharmacology - the science or study of drugs: their preparation and properties and uses and effects
Translations

phar·ma·co·ki·net·ics

n. farmacocinética, estudio in vivo del metabolismo y acción de las drogas.
References in periodicals archive ?
introduce the blending of pharmakinetics and pharmacodynamics with the newer discipline of pharmacogenetics, which takes into account genetic variations in individuals' responses to drug therapies.
His experience also includes co-founding and serving as general manager of PatientQuest, a clinical trial market research firm, as well as senior leadership roles for Acurian, Telerx Marketing, Telespectrum Worldwide and PharmaKinetics Laboratories.
With the acquisition of PharmaKinetics Laboratories Inc.
The subcommittee unanimously agreed that despite the small number of HIV-infected neonates born each year, data from safety and pharmakinetics studies of new antiretroviral drugs to be used in neonates and children are necessary.
Bioanalytical Systems launched its West Coast franchise in December and looks to expand its facilities on the East Coast early in 2003 with the acquisition of PharmaKinetics Laboratories, an early stage clinical trials lab.